International Assets Investment Management LLC Buys 5,290,025 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

International Assets Investment Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 78,814.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,296,737 shares of the healthcare conglomerate’s stock after acquiring an additional 5,290,025 shares during the quarter. International Assets Investment Management LLC owned about 0.57% of UnitedHealth Group worth $3,096,896,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Key Client Fiduciary Advisors LLC bought a new stake in UnitedHealth Group in the first quarter valued at $212,000. Wealthcare Advisory Partners LLC boosted its holdings in shares of UnitedHealth Group by 6.3% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock valued at $2,727,000 after buying an additional 326 shares in the last quarter. Signet Financial Management LLC boosted its holdings in shares of UnitedHealth Group by 8.0% during the 1st quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock valued at $358,000 after buying an additional 54 shares in the last quarter. Agate Pass Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 25.2% during the 1st quarter. Agate Pass Investment Management LLC now owns 497 shares of the healthcare conglomerate’s stock valued at $246,000 after buying an additional 100 shares in the last quarter. Finally, Janiczek Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 4.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 1,814 shares of the healthcare conglomerate’s stock valued at $897,000 after buying an additional 82 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $564.48 on Thursday. The stock has a market capitalization of $521.25 billion, a PE ratio of 36.77, a P/E/G ratio of 1.67 and a beta of 0.58. The firm has a 50 day moving average of $584.16 and a two-hundred day moving average of $536.49. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $6.56 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent analyst reports. Robert W. Baird lifted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.